Ovid Therapeutics, Inc. (OVID)
2.375
-0.10
(-3.85%)
USD |
NASDAQ |
Oct 22, 16:00
2.375
0.00 (0.00%)
After-Hours: 20:00
Ovid Therapeutics Profit Margin (Quarterly) : -2.05K% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.05K% |
| March 31, 2026 | |
| December 31, 2025 | |
| September 30, 2025 | -9.21K% |
| June 30, 2025 | -74.68% |
| March 31, 2025 | -7.87K% |
| December 31, 2024 | -12.18K% |
| September 30, 2024 | -8.10K% |
| June 30, 2024 | |
| March 31, 2024 | -7.90K% |
| December 31, 2023 | -10.82K% |
| September 30, 2023 | -10.32K% |
| Date | Value |
|---|---|
| June 30, 2023 | -16.54K% |
| March 31, 2023 | -20.18K% |
| December 31, 2022 | -24.85K% |
| September 30, 2022 | -107.8K% |
| June 30, 2022 | |
| March 31, 2022 | -1.11K% |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | 80.89% |
| December 31, 2020 | -386.3% |
| September 30, 2020 | -237.6% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 10.23% |
| Alnylam Pharmaceuticals, Inc. | 12.74% |
| Anika Therapeutics, Inc. | 10.15% |
| Savara, Inc. | -- |
| Vericel Corp. | 2.85% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -26.98% |
| Return on Assets | -23.00% |
| Return on Invested Capital | -24.41% |
| Gross Profit Margin (Quarterly) | 97.82% |
| Operating Margin (Quarterly) | -2.14K% |
| Return on Net Operating Assets | -291.1% |